Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
University of Kent Featured PhD Programmes
University of St Andrews Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
University of Reading Featured PhD Programmes
"brain" AND "cancer"×
10 miles

brain cancer PhD Projects, Programs & Scholarships

We have 21 brain cancer PhD Projects, Programs & Scholarships

  • "brain" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 21
  MRC Precision Medicine DTP: Quantitative proteomic analysis of dysregulated adhesion protein localisation in patient-derived cancer cells
  Research Group: Edinburgh Cancer Research Centre
  Dr A Byron, Prof M Frame, Prof R Zubarev, Dr A Sims
Application Deadline: 7 January 2019
Summary. This project seeks to use proteomic data and computational approaches to identify signatures of cell adhesion proteins that are mislocalised in cells from brain cancer patients.
  Understanding the molecular mechanisms which drive brain cancer recurrence and defining novel therapies to target these aggressive tumour cell populations
  Dr B Day
Application Deadline: 30 April 2019
Glioblastoma (GBM) is the most common and aggressive adult primary brain cancer. Median survival is. As part of the QIMR-Berghofer Brain Cancer Tissue Bank, we have collected a series of patient specimens which include primary tumours that have not undergone treatment and matching post-treatment recurrent tumours.
  Regulation of mRNA Translation in Brain Cancer
  Research Group: Centre for Cancer Research and Cell Biology
  Dr SM Jafarnejad
Application Deadline: 20 January 2019
mRNA translation is a complex mechanism, as part of the gene expression process, that results in synthesis of proteins. The translation machinery is tightly controlled in normal cells but cancer cells hijack it to further their cause of abnormal growth.
  PhD in Cancer Research - Targeting neuroinflammation in mTORC1-driven brain tumours
  Dr A Tee, Prof A Harwood
Application Deadline: 28 February 2019
This project will not only create a new brain tumour model, but will also give us valuable information on mTOR’s involvement in the development of brain tumours.
  Radiomics for cancer diagnosis and patient outcome prediction
  Dr J Korte, Dr N Hardcastle
Applications accepted all year round
adiomics is an emerging field that aims to extract vital information from growing collections of medical imaging and patient data.
  How does amino acid metabolism affect tumour growth?
  Dr L. Cheng
Applications accepted all year round
The effect of diet on tumour growth is hotly debated but poorly characterized. Due to the heterogeneous nature of the tumours, dietary studies in patients with varied genetic background often led to inconclusive outcome.
  Carbon nanotubes in the boron neutron capture therapy of cancer
  Dr G Calabrese
Applications accepted all year round
The early promise of boron neutron capture therapy as a method for the treatment of brain cancer has been mainly inhibited by the inherent toxicity associated with 10B-containing pharmacophores and the need for the ability to cross biological membranes.
  MRC DiMeN Doctoral Training Partnership: Gene expression network analysis to identify candidate drivers of treatment resistance in glioblastoma multiforme
  Dr A Droop, Dr L Stead, Prof D R Westhead
Application Deadline: 21 January 2019
Glioblastoma (GBM) is an incurable brain cancer. Patients survive an average 14 months post-diagnosis, despite receiving surgery and intensive chemoradiation because 100% of tumours grow back.
  Non-canonical G protein signalling of US28 as a new target for glioblastoma
  Research Group: Centre for Experimental Medicine
  Dr B Plouffe, Dr E Evergren
Application Deadline: 20 January 2019
Glioblastoma (GBM) is an aggressive type of brain cancer with poor clinical outcome. For most of GBM cases, infection by the human cytomegalovirus (HCMV) expressing the chemokine receptor US28 is responsible of this disease.
  Genetic and molecular mechanisms of brain structural plasticity and neurodegeneration
  Research Group: BBSRC MIBTP
  Dr A Hidalgo
Applications accepted all year round
The project will test the potential of a molecular mechanism that we recently discovered, in modulating brain structural plasticity versus neurodegeneration.
Show 10 15 30 per page

FindAPhD. Copyright 2005-2018
All rights reserved.